Droxidopa in Treating Patients With Neurogenic Hypotension

Completed · Not applicable

Conditions studied: Shy-Drager Syndrome, Orthostatic Hypotension

In brief

Please note that the continuation study can be found at http://clinicaltrials.gov/show/NCT00633880. RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from a lying down to a standing position or after eating a meal. It causes one to feel dizzy, light headed, and weak. Neurogenic hypotension is caused by a problem in the part of the nervous system that controls such functions as heart rate and blood pressure. Droxidopa, a drug that may increase blood pressure, may be an effective treatment for neurogenic hypotension. PURPOSE: Clinical trial to study the effectiveness of droxidopa in treating patients who have neurogenic hypotension.

Key facts

Study ID

NCT00004478

Run by

Icahn School of Medicine at Mount Sinai

Starts

1999-03-01

Expected to finish

2006-03-01

Last updated by the study team

2008-09-18

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.